“Senate Republicans seek probe of Mylan EpiPen oversight” plus 9 more Reuters: Health News |
- Senate Republicans seek probe of Mylan EpiPen oversight
- Allergan to buy Tobira in push for fatty liver disease drugs
- GlaxoSmithKline names insider Emma Walmsley as new CEO
- Just going on vacation may change gene activity
- China Vitamin C price-fixing verdict voided by U.S. appeals court
- Giving babies eggs and nuts early may avert allergies
- Wearable activity trackers may not boost weight loss
- Are U.S. public schools prepared for an emergency?
- Drugmakers pledge to clean up antibiotic factories, curb overuse
- Amgen cholesterol drug reduces arterial plaque buildup: study
| Senate Republicans seek probe of Mylan EpiPen oversight Posted: 20 Sep 2016 07:18 PM PDT NEW YORK (Reuters) - Mylan NV faced new scrutiny over price hikes for its anti-allergy EpiPen on Tuesday, with U.S. lawmakers calling for a probe of oversight of the company's rebates to government healthcare plans, while West Virginia said it was investigating whether Mylan defrauded its Medicaid department. |
| Allergan to buy Tobira in push for fatty liver disease drugs Posted: 20 Sep 2016 03:50 PM PDT (Reuters) - Botox maker Allergan Plc, in its third acquisition this month, said it would pay up to $1.7 billion for Tobira Therapeutics Inc to get a leg up in the race to develop therapies for NASH, an incurable fatty liver disease closely linked to obesity. |
| GlaxoSmithKline names insider Emma Walmsley as new CEO Posted: 20 Sep 2016 09:05 AM PDT LONDON (Reuters) - GlaxoSmithKline said on Tuesday it had chosen its head of consumer healthcare, Emma Walmsley, as its new chief executive, after several months reviewing internal and external candidates. |
| Just going on vacation may change gene activity Posted: 20 Sep 2016 02:09 PM PDT (Reuters Health) - In a new study comparing a meditation retreat with just relaxing in the same locale, both options improved stress regulation, immune function and other cellular markers in the blood. |
| China Vitamin C price-fixing verdict voided by U.S. appeals court Posted: 20 Sep 2016 11:22 AM PDT NEW YORK (Reuters) - A U.S. appeals court on Tuesday threw out a $147.8 million price-fixing verdict against two Chinese companies that were accused of conspiring to raise prices and lower supply of vitamin C sold to U.S. purchasers. |
| Giving babies eggs and nuts early may avert allergies Posted: 20 Sep 2016 12:19 PM PDT (Reuters Health) - Infants who get a taste of eggs and peanuts starting when they're as young as 4 months old may have a lower risk of developing allergies to those foods than babies who try them later, a research review suggests. |
| Wearable activity trackers may not boost weight loss Posted: 20 Sep 2016 09:21 AM PDT (Reuters Health) - For young adults on a long-term healthy diet and exercise program, tracking activity with a wearable device may not lead to additional weight loss, according to a new study. |
| Are U.S. public schools prepared for an emergency? Posted: 20 Sep 2016 12:41 PM PDT (Reuters Health) - More than a fifth U.S. school districts lack comprehensive plans to respond to natural disasters, epidemic diseases or other emergencies, a new report finds. |
| Drugmakers pledge to clean up antibiotic factories, curb overuse Posted: 20 Sep 2016 04:04 AM PDT (Reuters) - Thirteen leading drugmakers promised on Tuesday to clean up pollution from factories making antibiotics and take steps to curb overuse of the medicines as part of a drive to fight the rise of drug-resistant superbugs. |
| Amgen cholesterol drug reduces arterial plaque buildup: study Posted: 20 Sep 2016 08:56 AM PDT (Reuters) - Amgen Inc said on Tuesday its potent new cholesterol fighter, Repatha, met the primary and secondary goals of a study designed to show it can decrease plaque buildup in heart arteries of patients already taking widely used statin drugs, such as Lipitor. |
| You are subscribed to email updates from Reuters: Health News. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
Lexo edhe:
